Clinical Trials Logo

Clinical Trial Summary

All heart surgery patients universally require hydration, which is given through a vein in the arm, but practices for treating patients are not universal. There are disagreements about whether crystalloids should be used alone or in combination with albumin. This question has important implications because albumin is an expensive blood product in relatively limited supply, and 20% of its use is by heart surgery patients. The goal of this study is to learn more about how crystalloids and albumin are used during heart surgery, as well as, key patient outcomes.


Clinical Trial Description

The goal of this proposed multicentre retrospective cohort study is to characterize perioperative usage patterns of crystalloids and albumin, as well as key patient outcomes, in cardiac surgical patients. This study will also address numerous other knowledge gaps in the area of perioperative blood product management and fluid administration in cardiac surgery and define a collaborative group to support future research in this field. The primary objective is to obtain granular information on if, when, and how albumin is given perioperatively to cardiac surgical patients. This includes the doses and settings in which albumin is used, the types of crystalloid solutions (balanced or unbalanced) used, and when albumin is used (for example, while on cardio-pulmonary bypass, in the ICU, or on the ward) in perioperative cardiac surgical care across institutions. This important information about the scope of albumin and crystalloid use across the country will inform the design of our future intervention and control arms in the planned definitive trial. ;


Study Design


Related Conditions & MeSH terms

  • Cardiovascular Surgical Procedures

NCT number NCT06322537
Study type Observational
Source University Health Network, Toronto
Contact Justyna Bartoszko, MD MSc FRCPC
Phone 416-340-4800
Email actu@uhn.ca
Status Not yet recruiting
Phase
Start date April 2, 2024
Completion date November 1, 2025

See also
  Status Clinical Trial Phase
Completed NCT02463123 - Energy Expenditure Estimation in Cardiac Surgery N/A
Completed NCT00211913 - StaphVAX in Cardiovascular Surgery Patients Phase 3
Completed NCT02557672 - PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding Phase 4
Active, not recruiting NCT00114036 - Trial to Reduce Antimicrobial Prophylaxis Errors (TRAPE) N/A
Recruiting NCT04762576 - Thrombin in Cardiac Surgery
Completed NCT00270023 - A Study to Determine the Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Non-anemic Patients Who Are Undergoing Orthopedic, Heart and Blood Vessel, or Breast Reduction Surgery; Performed in Combination With a Procedure to Reduce Blood Loss During Surgery. Phase 2/Phase 3